The IC50 of my drug in my cell line (MSTO) is 25 nM.

I recently did a Caspase-3 assay using 2.5 nM, and the relative caspase-3 activity increased to 300 compared to the untreated control. This is a similar increase to that I've seen in another cell line (Ren) where the IC50 is 2.5 nM!

What could be the reasons behind this? Can cells be viable according to an MTT while going through apoptosis?

Note: My drug is an ADC that binds to mesothelin. Ren cells expressed mesothelin, MSTO don't (well, 10 % ish).

More Aimee Parsons's questions See All
Similar questions and discussions